- NOVEL COMPOUNDS AS MODULATORS OF GPR-119
-
The present invention relates to novel compounds of formula (A) and (B) as modulators of GPR-119, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of GPR-119 mediated diseases
- -
-
Page/Page column 75
(2013/02/27)
-
- INDOLE SULFONAMIDE MODULATORS OF PROGESTERONE RECEPTORS
-
Compounds of Formula (I), wherein n is 1 or 2, and R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein, their preparation, pharmaceutical compositions, and methods of use are disclosed.
- -
-
Page/Page column 24-25
(2008/06/13)
-
- 1H-PYRROLO[2,3-B]PYRIDINES
-
Derivatives of pyrrolo[2,3-b]pyridine which are useful as SGK-1 kinase inhibitors are described herein. The invention described herein also describes pharmaceutical compositions containing derivatives of pyrrolo[2,3-b]pyridine and methods of using pyrrolo[2,3-b]pyridine derivatives and pharmaceutical compositions thereof in the treatment of diseases mediated by SGK-1.
- -
-
Page/Page column 53
(2008/06/13)
-
- OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS
-
The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria, for example, multiple-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms, for example, Bacterioides spp. and Clostridia spp. species, and acid fast organisms, for example, Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.
- -
-
Page/Page column 81-82
(2010/10/20)
-